Implantable Cardiac Monitors Market – Global Market Size, Strategic Growth Drivers, Risk Assessment Framework, Regulatory Landscape Review, Competitive Intensity Mapping & Long-Term Industry Outlook to 2034
Overview
The Implantable Cardiac Monitors Market size was valued at USD 720.04 Million in 2025 and the total Implantable Cardiac Monitors revenue is expected to grow at a CAGR of 7.57% from 2026 to 2034, reaching nearly USD 1388.60 Million.
The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.
Implantable Cardiac Monitors Market Growth and Share Analysis
To know about the Research Methodology:-Request Free Sample Report
Implantable Cardiac Monitors Market Dynamics:
An implantable cardiac monitor, also known as an implantable loop recorder, is a small insertable device that constantly monitors heart rhythms. These monitors are considered as the gold standard for estimating irregular and unexplained arrhythmias.
The major driving factor behind the market growth is the durability of implantable cardiac monitors. Additionally, implanting a cardiac monitor requires less duration, so fewer hospital stays and fewer hospital readmission are required. On the other hand, the availability of alternative modes of treatments and high expenditures of implantable cardiac monitors is limiting the growth of the Implantable Cardiac Monitors market. Also, increasing awareness of devices and treatment options for cardiac disorders will create productive opportunities for the key players in this market.
The Implantable Cardiac Monitors Market has met significant development in the recent years and is expected to grow massively during the forecast period. Implantable cardiac monitors (ICM) are tiny electrophysiology devices that are used for monitoring a patient's heart movement for a long period of time. These additionally helping in recognizing arrhythmias. The technology of implantable cardiac monitor can wipe out the necessity for mass outer Holter screen, which needs a wire to be connected to a patient.
ICM is a framework that is used to monitor heart failure that prevents hospitalization of patients. ICMs are inserted under the skin of the patient. These monitors help doctors to estimate the health of patients by making use of cardiac rhythm. Additionally, these are used for monitoring many cardiovascular issues, for example, atrial fibrillation, heart failure, and signs of a recent heart attack.
Two main equipment used for cardiac arrhythmias are Electrocardiogram (ECG) and Holter monitor. Usage of ECG monitoring devices and services are increasing rapidly over the past decade. ECG has penetrated into various departments due to its wide use in mobile cardiac outpatient telemetry and currently in data management for electronic medical records (EMR). A growing number of life-threatening cardiac diseases are resulting in an increase in the demand for ECG monitoring devices and services in hospitals and diagnostics laboratories with essential and advanced software services. The above-mentioned factors will increase the demand for ECG monitoring devices, data management, and services in large integrated healthcare systems.
Atrial Fibrillation cases within the elderly population, preference for catheter ablation, and escalating technological developments are boosting the AF market growth. Atrial fibrillation is a majorly common arrhythmia that results in disturbed cardiac rhythms. In the last twenty years, a higher presence of AF incidences has been witnessed around the globe. The ‘American Heart Association’ stated that about 34 million people were afflicted with AF globally in 2013.
North America dominates the global implantable cardiac monitor market, due to the high adoption rate of technologically advanced implantable cardiac monitors, the presence of highly sophisticated healthcare infrastructure and favourable reimbursement framework, and the presence of major players in North America. Implantable cardiac monitors are niche, and this provides major opportunities for companies to enlarge and invest in the region. Similarly, a rise in the prevalence of cardiovascular conditions that require advanced monitoring contributes to the demand for implantable cardiac monitors.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data, and projections with a suitable set of assumptions and methodology. The report also helps in understanding Implantable Cardiac Monitors Market dynamics, structure by identifying and analyzing the market segments and project the global market size.
Further, the report also focuses on competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in near future to emerging segment in Implantable Cardiac Monitors Market.
Implantable Cardiac Monitors Market, Key Highlights:
1. Global Implantable Cardiac Monitors Market analysis and forecast, in terms of value.
2. Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Implantable Cardiac Monitors Market
3. Global Implantable Cardiac Monitors Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.
4. Global Implantable Cardiac Monitors Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.
5. Global Implantable Cardiac Monitors Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.
6. Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.
7. Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Implantable Cardiac Monitors Market are also profiled.
Implantable Cardiac Monitors Market Recent Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 18 December 2025 | Abbott Laboratories | Abbott secured U.S. FDA 510(k) clearance for its AI-powered Assert-IQ™ Insertable Cardiac Monitor System (Model DM5100). | The regulatory approval expands Abbott’s continuous cardiac monitoring portfolio with enhanced automated arrhythmia detection capabilities for long-term patient care. |
| 28 January 2026 | BIOTRONIK | BIOTRONIK achieved its first-in-human implantations of the LivIQ leadless pacemaker system featuring advanced far-field sensing technology. | The successful initial procedures advance the commercial clinical trial pathway for next-generation remote cardiac monitoring and pacing integration. |
| 03 February 2026 | Circadia Health | Circadia Health received U.S. FDA 510(k) clearance for the Circadia C300 System for continuous cardiorespiratory diagnostics. | The approval delivers a contactless continuous radar-based monitoring solution to skilled nursing facilities to identify early cardiac and respiratory deterioration. |
| 05 March 2026 | Knowles Corporation | Knowles expanded manufacturing of ISO 13485-certified Class 1 MLCC components at its Norwich plant specifically for implantable cardiac monitors. | The production surge addresses strict EU post-market surveillance mandates and shortens OEM component supply chain lead times for biocompatible cardiac monitors. |
| 10 August 2026 | iRhythm Technologies | iRhythm Technologies entered into a definitive agreement to acquire VitalConnect for $287.5 million. | The acquisition expands iRhythm's continuous cardiac telemetry portfolio into a $1 billion mobile cardiac monitoring addressable market. |
Implantable Cardiac Monitors Market Scope: Inquire before buying
| Implantable Cardiac Monitors Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 720.04 Mn. |
| Forecast Period 2026 to 2034 CAGR: | 7.57% | Market Size in 2034: | USD 1388.60 Mn. |
| Segments Covered: | by Indication | Cardiac Arrhythmias Atrial Fibrillation Epilepsy & Unexplained Falls |
|
| by End-User | Hospitals Cardiac Center & Clinics Ambulatory Surgical Centers (ASCs) |
||
Implantable Cardiac Monitors Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Implantable Cardiac Monitors Market, Key Players
1. Abbott Laboratories
2. Biotronik SE & Co. KG
3. Boston Scientific Corporation
4. Edwards Lifescience Corporation
5. General Electric Company
6. Koninklijke Philips N.V.
7. LivaNova PLC
8. Medtronic plc
9. Nihon Kohden Corporation
10.Phoenix Heart Center
11.Astellas Pharma, Inc.
12.Sigma-Aldrich Corporation
13.Agilent Technologies, Inc.
14.ReliantHeart Inc.
15.Abiomed, Inc.
16.Basilea Pharmaceutical Ltd.
17.Berlin Heart GmbH
18.Schiller AG
19.Jarvik Heart, Inc
Frequently Asked Questions:
1. Which region has the largest share in Global market?
Ans: North America region holds the highest share in 2025.
2. What was the Global Implantable Cardiac Monitors Market size in 2025?
Ans: The Global Implantable Cardiac Monitors Market size was USD 720.04 Million in 2025.
3. What is scope of the Global market report?
Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global market?
Ans: The important key players in the Global market are – Abbott Laboratories,Biotronik SE & Co. KG,Boston Scientific Corporation,Edwards Lifescience Corporation,General Electric Company,Koninklijke Philips N.V.,LivaNova PLC,Medtronic plc,Nihon Kohden Corporation,Phoenix Heart Center,Astellas Pharma, Inc.,Sigma-Aldrich Corporation,Agilent Technologies, Inc.,ReliantHeart Inc.,Abiomed, Inc.,Basilea Pharmaceutical Ltd.,Berlin Heart GmbH,Schiller AG,Jarvik Heart, Inc.
5. What is the study period of this market?
Ans: The Global Implantable Cardiac Monitors Market is studied from 2020 to 2034.